Specialty drugs

Results: 87



#Item
21Press Release Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency BENGALURU, India and HERTFORDSHIRE, England/PITTSBURGH, USA, July 21, 20

Press Release Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency BENGALURU, India and HERTFORDSHIRE, England/PITTSBURGH, USA, July 21, 20

Add to Reading List

Source URL: www.biocon.com

Language: English - Date: 2016-07-21 09:25:25
22GRADUATE ASSISTANTS OPEN ENROLLMENT AND BENEFITS NEWS Open Enrollment is your opportunity to review and update your benefit choices for the coming year. Be sure to take action November 2–13, 2015, if you wish to make a

GRADUATE ASSISTANTS OPEN ENROLLMENT AND BENEFITS NEWS Open Enrollment is your opportunity to review and update your benefit choices for the coming year. Be sure to take action November 2–13, 2015, if you wish to make a

Add to Reading List

Source URL: openenrollment.syr.edu

Language: English - Date: 2015-10-30 17:11:15
23Hubbard County Coverage Period: Beginning on or afterSummary of Benefits and Coverage: What this Plan covers & What it CostsCoverage for: Single coverage only | Plan Type: HSA This is only a summary. If you w

Hubbard County Coverage Period: Beginning on or afterSummary of Benefits and Coverage: What this Plan covers & What it CostsCoverage for: Single coverage only | Plan Type: HSA This is only a summary. If you w

Add to Reading List

Source URL: co.hubbard.mn.us

Language: English - Date: 2015-11-02 14:56:16
24This is an electronically controlled document. User is responsible to verify and use the current revision. GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a

This is an electronically controlled document. User is responsible to verify and use the current revision. GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a

Add to Reading List

Source URL: www.gilead.com

Language: English - Date: 2015-10-19 17:28:06
25Value Drug Provides Quality Platform to Improve Patient Outcomes to Pharmacy Co-op Press Release For Immediate Release May 25, 2014 Contact: Kathy Kilgore

Value Drug Provides Quality Platform to Improve Patient Outcomes to Pharmacy Co-op Press Release For Immediate Release May 25, 2014 Contact: Kathy Kilgore

Add to Reading List

Source URL: www.pharmacyquality.com

Language: English - Date: 2016-04-13 09:02:00
26Specialty Pharmacy Pricing Paper JID MARCH2014

Specialty Pharmacy Pricing Paper JID MARCH2014

Add to Reading List

Source URL: www.artemetrx.com

Language: English - Date: 2014-08-29 09:13:25
27xeloda oral solution recipe average dosage of xeloda xeloda cancer medication detoxification before taking xeloda xeloda copay assistance. cancer colon for xeloda. xeloda sensitizer. xeloda cancer spread control

xeloda oral solution recipe average dosage of xeloda xeloda cancer medication detoxification before taking xeloda xeloda copay assistance. cancer colon for xeloda. xeloda sensitizer. xeloda cancer spread control

Add to Reading List

Source URL: milfordk12.org

Language: English - Date: 2016-08-20 17:42:00
28Crescendo Biologics Appoints Dr Barbara Fleck as Head of Intellectual Property Cambridge, UK: 2 February 2016 – Crescendo Biologics Limited (Crescendo), the drug discovery and developer of Humabody™ VH therapeutics,

Crescendo Biologics Appoints Dr Barbara Fleck as Head of Intellectual Property Cambridge, UK: 2 February 2016 – Crescendo Biologics Limited (Crescendo), the drug discovery and developer of Humabody™ VH therapeutics,

Add to Reading List

Source URL: www.crescendobiologics.com

Language: English - Date: 2016-04-15 08:53:48
29NOVARTIS PHARMACEUTICALS TO PAY $390 MILLION IN KICKBACK SETTLEMENT The National Association of Medicaid Fraud Control Units (NAMFCU) announced on November 20, 2015 that federal government, 45 states and the District of

NOVARTIS PHARMACEUTICALS TO PAY $390 MILLION IN KICKBACK SETTLEMENT The National Association of Medicaid Fraud Control Units (NAMFCU) announced on November 20, 2015 that federal government, 45 states and the District of

Add to Reading List

Source URL: www.namfcu.net

Language: English - Date: 2016-03-31 16:45:50
30New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S. Results of retrospective analysis show use of newer anti-epilepsy drugs, access to specialty care, and deliberat

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S. Results of retrospective analysis show use of newer anti-epilepsy drugs, access to specialty care, and deliberat

Add to Reading List

Source URL: www.ucb-usa.com

Language: English - Date: 2016-01-20 09:39:35